Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs JUBILANT PHARMOVA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN JUBILANT PHARMOVA LUPIN/
JUBILANT PHARMOVA
 
P/E (TTM) x 40.7 -2,647.7 - View Chart
P/BV x 6.0 1.7 356.5% View Chart
Dividend Yield % 0.2 0.9 28.1%  

Financials

 LUPIN   JUBILANT PHARMOVA
EQUITY SHARE DATA
    LUPIN
Mar-23
JUBILANT PHARMOVA
Mar-23
LUPIN/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs799496 161.2%   
Low Rs583269 216.9%   
Sales per share (Unadj.) Rs365.8394.4 92.7%  
Earnings per share (Unadj.) Rs9.8-4.1 -241.6%  
Cash flow per share (Unadj.) Rs29.230.7 95.1%  
Dividends per share (Unadj.) Rs4.005.00 80.0%  
Avg Dividend yield %0.61.3 44.2%  
Book value per share (Unadj.) Rs270.7338.6 79.9%  
Shares outstanding (eoy) m454.98159.28 285.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.91.0 194.9%   
Avg P/E ratio x70.2-93.8 -74.8%  
P/CF ratio (eoy) x23.712.4 190.2%  
Price / Book Value ratio x2.61.1 226.2%  
Dividend payout %40.7-122.7 -33.1%   
Avg Mkt Cap Rs m314,38160,873 516.5%   
No. of employees `000NANA-   
Total wages/salary Rs m30,87221,660 142.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,41762,817 264.9%  
Other income Rs m1,509383 393.7%   
Total revenues Rs m167,92663,201 265.7%   
Gross profit Rs m17,2067,317 235.2%  
Depreciation Rs m8,8075,540 159.0%   
Interest Rs m2,7431,882 145.8%   
Profit before tax Rs m7,165278 2,579.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,688927 290.1%   
Profit after tax Rs m4,477-649 -690.0%  
Gross profit margin %10.311.6 88.8%  
Effective tax rate %37.5333.5 11.2%   
Net profit margin %2.7-1.0 -260.5%  
BALANCE SHEET DATA
Current assets Rs m124,51337,624 330.9%   
Current liabilities Rs m92,65417,724 522.8%   
Net working cap to sales %19.131.7 60.4%  
Current ratio x1.32.1 63.3%  
Inventory Days Days2625 106.9%  
Debtors Days Days9856 176.0%  
Net fixed assets Rs m103,49071,668 144.4%   
Share capital Rs m910159 572.0%   
"Free" reserves Rs m122,24653,772 227.3%   
Net worth Rs m123,15653,931 228.4%   
Long term debt Rs m27531,104 0.9%   
Total assets Rs m228,003109,292 208.6%  
Interest coverage x3.61.1 314.7%   
Debt to equity ratio x00.6 0.4%  
Sales to assets ratio x0.70.6 127.0%   
Return on assets %3.21.1 280.6%  
Return on equity %3.6-1.2 -302.2%  
Return on capital %8.02.5 316.0%  
Exports to sales %00-   
Imports to sales %04.1 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA2,564 0.0%   
Fx inflow Rs m48,0577,100 676.9%   
Fx outflow Rs m21,7522,564 848.3%   
Net fx Rs m26,3064,536 580.0%   
CASH FLOW
From Operations Rs m18,9726,607 287.2%  
From Investments Rs m-12,868-5,444 236.4%  
From Financial Activity Rs m-3,373-1,567 215.2%  
Net Cashflow Rs m2,732301 907.7%  

Share Holding

Indian Promoters % 46.8 47.4 98.7%  
Foreign collaborators % 0.3 3.3 8.5%  
Indian inst/Mut Fund % 45.8 23.2 197.8%  
FIIs % 16.1 20.3 79.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 49.3 107.4%  
Shareholders   281,542 86,588 325.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs Jubilant Pharmova

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs Jubilant Pharmova Share Price Performance

Period Lupin Jubilant Pharmova S&P BSE HEALTHCARE
1-Day 1.23% -0.54% 1.18%
1-Month 0.15% 2.20% -0.75%
1-Year 151.14% 109.28% 61.82%
3-Year CAGR 17.13% -6.79% 18.16%
5-Year CAGR 17.42% -2.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the Jubilant Pharmova share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of Jubilant Pharmova the stake stands at 50.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of Jubilant Pharmova.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

Jubilant Pharmova paid Rs 5.0, and its dividend payout ratio stood at -122.7%.

You may visit here to review the dividend history of Lupin, and the dividend history of Jubilant Pharmova.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.